文献速递中医内科中药与中成药合理使用中医儿科

虎杖治疗成人及儿童急性呼吸道感染的系统评价

Reynoutria japonica Houtt for Acute Respiratory Tract Infections in Adults and Children: A Systematic Review.
PubMed 文献 · Front Pharmacol · 2022-02-24

该系统评价纳入8项RCT共1123例急性呼吸道感染患者,所有试验均将虎杖作为复方草药的一部分使用。Meta分析显示含虎杖的草药复方提高症状改善率(RR 1.14,95%CI [1.09, 1.20]),缩短发热时间,降低Murray肺损伤评分,且未增加不良事件(RR 0.33,95%CI [0.11, 1.00])。结论为有限证据提示虎杖作为复方组成部分可能有效且安全。

要点

  • 含虎杖的复方草药可提高急性呼吸道感染症状改善率。
  • 含虎杖的复方草药可缩短发热时间并降低Murray肺损伤评分。
  • 含虎杖的复方草药未增加不良事件,但证据有限。

核心结论

  • 有限证据提示虎杖作为复方草药组成部分可能对急性呼吸道感染有效且安全。

研究设计与样本

  • 系统评价纳入8项RCT,共1123例急性呼吸道感染参与者,所有试验均将虎杖作为复方草药的一部分使用。

主要发现

  • 含虎杖的草药复方提高症状改善率(RR 1.14,95%CI [1.09, 1.20],I2 = 0%,p < 0.00001,n = 7项试验,1013例参与者)。
  • 含虎杖的草药复方缩短发热时间并降低Murray肺损伤评分。
  • 含虎杖的草药复方未增加不良事件(RR 0.33,95%CI [0.11, 1.00],I2 = 0%,p = 0.05,n = 5项试验,676例参与者)。

临床怎么用

  • 在临床实践中,可考虑将虎杖作为复方草药组成部分用于急性呼吸道感染,但需注意证据有限。

局限性

  • 仅一项纳入试验的治疗组使用不含抗生素的虎杖复方草药。
  • 所有试验均使用虎杖作为复方组成部分,非单味药。
  • 未来研究宜评估不含抗生素的虎杖治疗急性呼吸道感染的有效性与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction: Respiratory tract infections (RTIs) are a major cause of morbidity and mortality in some high-risk groups including children and older adults. There is evidence that Chinese herbal medicine has an effect on RTIs. Reynoutria japonica Houtt (better known under its synonym Fallopia japonica (Houtt.) Ronse Decr.) (F. japonica), a commonly used Chinese herbal medicine, has a high content of resveratrol and glycosides. In traditional Chinese medicine theory, F. japonica has the effect of clearing heat in the body, improving blood and qi circulation, eliminating phlegm, and relieving cough, so it may have an effect on RTIs. Methods: This systematic review was registered under PROSPERO CRD42020188604. Databases were searched for randomized controlled trials of F. japonica as a single herb, or as a component of a complex herbal formula for RTIs. Quality of methodology was assessed by two reviewers independently using the Cochrane Risk of Bias Tool. The primary outcome was symptom improvement rate. The secondary outcome measures were fever clearance time, Murray lung injury score and incidence of adverse effects. The extracted data were pooled and meta-analysed by RevMan 5.3 software. Results: Eight RCTs with 1,123 participants with acute RTIs were included in this systematic review, and all the RCTs used F. japonica as part of a herbal mixture. Only one included trial used F. japonica in a herbal mixture without antibiotics in the treatment group. The findings showed that herbal remedies that included F. japonica could increase the symptom improvement rate (risk ratio 1.14, 95% confidence intervals [1.09, 1.20], I2 = 0%, p < 0.00001, n = 7 trials, 1,013 participants), shorten fever duration, reduce Murray lung injury score and did not increase adverse events (RR 0.33, 95% CI [0.11, 1.00], I2 = 0%, p = 0.05, n = 5 trials, 676 participants). Conclusion: There is limited but some evidence that F. japonica as part of a herbal mixture may be an effective and safe intervention for acute RTIs in clinical practice. In future studies it would be preferable to evaluate the effectiveness and safety of using F. japonica without antibiotics for acute RTIs.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wang ZJ, Trill J, Tan LL, et al. Reynoutria japonica Houtt for Acute Respiratory Tract Infections in Adults and Children: A Systematic Review. Front Pharmacol. 2022. PMID: 35281919. doi:10.3389/fphar.2022.787032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。